Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study.
Liu R, Liu L, Zhao C, Bai Y, Zheng Y, Zhang S, Li N, Yang J, Fan Q, Wang X, Zeng S, Zhang Y, Zhang W, Zhuang Y, Kang N, Jiang Y, Sun H, Xu J. Liu R, et al. Among authors: zhuang y. BMC Gastroenterol. 2021 Oct 23;21(1):398. doi: 10.1186/s12876-021-01982-4. BMC Gastroenterol. 2021. PMID: 34688250 Free PMC article. Clinical Trial.
New biomarker for lung cancer - focus on circSETD3.
Tao F, Gu C, Li N, Ying Y, Cao LF, Xiao QF, Ni D, Zhuang YB, Zhang Q. Tao F, et al. Among authors: zhuang yb. J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2):583-591. doi: 10.23812/20-664-L. J Biol Regul Homeost Agents. 2021. PMID: 33768996
Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations: A phase 1b clinical trial and biomarker analysis.
Zhao S, Ma Y, Liu L, Fang J, Ma H, Feng G, Xie B, Zeng S, Chang J, Ren J, Zhang Y, Xi N, Zhuang Y, Jiang Y, Zhang Q, Kang N, Zhang L, Zhao H. Zhao S, et al. Among authors: zhuang y. Lung Cancer. 2024 Feb;188:107468. doi: 10.1016/j.lungcan.2024.107468. Epub 2024 Jan 3. Lung Cancer. 2024. PMID: 38181454 Clinical Trial.
Cationic peptides cause memory loss through endophilin-mediated endocytosis.
Stokes EG, Vasquez JJ, Azouz G, Nguyen M, Tierno A, Zhuang Y, Galinato VM, Hui M, Toledano M, Tyler I, Shi X, Hunt RF, Aoto J, Beier KT. Stokes EG, et al. Among authors: zhuang y. Nature. 2025 Jan 15. doi: 10.1038/s41586-024-08413-w. Online ahead of print. Nature. 2025. PMID: 39814881
Corrigendum to "Comparative study of transcriptomic alterations in sepsis-induced acute liver injury: Deciphering the role of alternative splicing in mouse models" [Int. Immunopharmacol. 146 (2025) 113878].
Nie K, Kadier A, Jia S, Liu D, Tong N, Tuerxun M, Aisha A, Peng H, Zhuang Y, Chen Y, Jiang J, Sun M, Fang Y, Chen H. Nie K, et al. Among authors: zhuang y. Int Immunopharmacol. 2025 Jan 13:114077. doi: 10.1016/j.intimp.2025.114077. Online ahead of print. Int Immunopharmacol. 2025. PMID: 39809677 No abstract available.
RBBP6 anchors pre-mRNA 3' end processing to nuclear speckles for efficient gene expression.
Yoon Y, Bournique E, Soles LV, Yin H, Chu HF, Yin C, Zhuang Y, Liu X, Liu L, Jeong J, Yu C, Valdez M, Tian L, Huang L, Shi X, Seelig G, Ding F, Tong L, Buisson R, Shi Y. Yoon Y, et al. Among authors: zhuang y. Mol Cell. 2025 Jan 8:S1097-2765(24)01033-5. doi: 10.1016/j.molcel.2024.12.016. Online ahead of print. Mol Cell. 2025. PMID: 39798570
4,257 results